Skip to main content
Illustrated ear buds.

Podcasts

Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs. Listen through our site or subscribe in iTunes or through your smartphone podcast app.

Signal Awards 2022 Silver Winner

Like our podcasts? Please consider leaving a review on iTunes or in your podcast app and sharing the series with your network.

 


  • Podcast: Meet the Newest Member of Your Care Team: The Smartwatch

    Podcast: Meet the Newest Member of Your Care Team: The Smartwatch

    Dr. William Marks talks to Dave Iverson about how wearable devices may help people with Parkinson's monitor their disease and help researchers test new therapies.
    Learn more

  • Podcast: Six New Genetic Risk Factors for Parkinson's Identified

    Podcast: Six New Genetic Risk Factors for Parkinson's Identified

    Scientists have found six new gene variants associated with Parkinson's, which could point to new treatment paths.
    Learn more

  • Podcast: What Causes "Off" Episodes?

    Podcast: What Causes "Off" Episodes?

    CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.
    Learn more

  • Podcast: Alzheimer’s and Parkinson’s, What’s the Connection?

    Podcast: Alzheimer’s and Parkinson’s, What’s the Connection?

    Mark Frasier, PhD, VP of research programs at MJFF, discusses what we know about the overlap between Alzheimer's and Parkinson's diseases.
    Learn more

  • Podcast: How Parkinson’s Variability Could Point to Personalized Treatments

    Podcast: How Parkinson’s Variability Could Point to Personalized Treatments

    The experience of Parkinson's disease is different for each patient. Studying that variability may allow researchers to develop personalized treatments for different subtypes of PD.
    Learn more

  • Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing

    Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing

    Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million from the NIH for Phase III testing.
    Learn more

The MJFF podcast series has been made possible through the leadership of members of ourParkinson's Disease Education Consortium in conjunction with The Albert B. Glickman Parkinson's Disease Education Program. These partners' support allows us to furnish high-quality educational content to the Parkinson's community while maintaining our commitment to allocate donor dollars to high-impact research. Editorial control of all Michael J. Fox Foundation-published content rests solely with the Foundation.

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Male and female researcher wearing white lab coats chatting in the lab.

Breaking Research Updates

Read the latest developments in the field’s understanding and treatment of Parkinson’s disease.

Read Research News
"As a newly diagnosed person with Parkinson's, the podcasts available from MJFF are a welcome source of information."
Podcast Review
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.